Related references
Note: Only part of the references are listed.Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy
Pierpaolo Correale et al.
JOURNAL OF IMMUNOTHERAPY (2010)
DC therapy induces long-term NK reactivity to tumors via host DC
Kanako Shimizu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Clinical Grade OK432-activated Dendritic Cells In Vitro Characterization and Tracking During Intralymphatic Delivery
Emma West et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties
Sebastien Anguille et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Reengineering dendritic cell-based anti-cancer vaccines
Gary K. Koski et al.
IMMUNOLOGICAL REVIEWS (2008)
Combined use of toll-like receptor agonists and prostaglandin E2 in the FastDC model:: Rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production
Marc Dauer et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma - A clinical, phase 1/2 trial
Annika Berntsen et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Memory T cells in cancer immunotherapy:: which CD8+ T-cell population provides the best protection against tumours?
R. Perret et al.
TISSUE ANTIGENS (2008)
Phase I/II study of vaccination with electrofused allogeneic dendritic Cells/Autologous tumor-derived cells in patients with stage IV renal cell carcinoma
David E. Avigan et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides
Brian Kavanagh et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy
Yuji Ueda et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
CD4+ CD25+ FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
Sarah L. Clarke et al.
PLOS ONE (2006)
NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity
Takuya Osada et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells
J Babatz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers
M Sakakibara et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Interleukin-12 secreted by mature dendritic cells mediates activation of NK cell function
RS Alli et al.
FEBS LETTERS (2004)
Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study
HS Pandha et al.
BJU INTERNATIONAL (2004)
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate
R Vilella et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cells
K Matsuda et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Mature dendritic cells derived from human monocytes within 48 hours: A novel strategy for dendritic cell differentiation from blood precursors
M Dauer et al.
JOURNAL OF IMMUNOLOGY (2003)
Critical role of MHC class I-related chain A and B expression on IFN-α-stimulated dendritic cells in NK cell activation:: Impairment in chronic hepatitis C virus infection
M Jinushi et al.
JOURNAL OF IMMUNOLOGY (2003)
A flow-cytometric NK-cytotoxicity assay adapted for use in rat repeated dose toxicity studies
M Marcusson-Stahl et al.
TOXICOLOGY (2003)
A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells:: implications for immunotherapy
AW Lee et al.
VACCINE (2002)
Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy
K Dredge et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
